Pharmafile Logo

long-term condition

- PMLiVE

Optimised therapy to improve outcomes for heart attack and stroke patients

Personalising therapy promises to revolutionise the treatment of thrombosis

- PMLiVE

The new era of medical affairs: busting myths and supercharging strategic value

‘MA creates the scientific conditions for long-term, trustworthy commercial success’

- PMLiVE

J&J’s Tremfya improves symptoms of psoriatic arthritis including joint damage

Psoriatic arthritis can develop in up to 30% of people with psoriasis

- PMLiVE

Novartis announces plans for new US manufacturing hub

The US hub is expected to create 700 new jobs by 2030

- PMLiVE

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio

- PMLiVE

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

Inizio

- PMLiVE

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links